Carvedilol significantly reduced mortality from cardiovascular causes and Study Rundown: The CAPRICORN trial demonstrated that. London, UK – Results of the CAPRICORN trial confirm the benefit of the beta blocker carvedilol (Coreg® – GlaxoSmithKline) in reducing. Description: The CArvedilol Post-infaRct survIval COntRolled evaluatioN ( CAPRICORN) trial was a randomized, placebo-controlled trial.
|Published (Last):||14 May 2005|
|PDF File Size:||4.52 Mb|
|ePub File Size:||20.64 Mb|
|Price:||Free* [*Free Regsitration Required]|
In patients treated long-term after an acute myocardial infarction complicated by left-ventricular systolic dysfunction, carvedilol reduced the frequency of all-cause and cardiovascular mortality, and recurrent, non-fatal myocardial infarctions. These beneficial effects are additional to those of evidence-based treatments for acute myocardial infarction including ACE inhibitors. A placebo-controlled, randomized trial. Generally, the patients recruited to these trials were at low risk: JAMA ; Am J Med ; 5: Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: Lopressor Intervention Trial Research Group.
METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. Effect of timing, dosage, and infarct location. J Am Coll Cardiol ;51 2: Article Tools How to cite item. Acta Med Scand ; 3: About the Capdicorn B.
Possible indications and treatment schemes for carvedilol in patients with acute MI are carvexilol. A randomised trial of propranolol in patients with acute myocardial infarction, I: We investigated the long-term efficacy of carvedilol on morbidity and mortality in patients with left-ventricular dysfunction after acute myocardial infarction treated according to current evidence-based practice. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: Effects of carvedilol early after myocardial infarction: Early intravenous then oral metoprolol in 45 patients with acute myocardial infarction: The Lopressor Intervention Trial: Van de Werf F.
After myocardial infarction carvedilol improves insulin resistance compared to metoprolol. Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention — the PASSAT Study. Effect on mortality of metoprolol in acute myocardial infarction. Randomised trial of intravenous atenolol among 16 cases of suspected acute myocardial infarction: Eur Heart J ;8 Am Heart J capricotn 4: Rational Pharmacotherapy in Cardiology.
CAPRICORN – Wiki Journal Club
Cardiovascular mortality, non-fatal myocardial infarctions, and all-cause mortality or non-fatal myocardial infarction were also lower on carvedilol than on placebo. Keywords myocardial infarction, beta-blocker, carvedilol, metoprolol. Pacing Capricofn Electrophysiol ;28 Suppl 1: S Food and Drug Administration.
User Username Password Remember me Not a user? Body weight changes with beta-blockers use: